Bertalan Németh

Biographic Data

ID10016649
NAMEBertalan Németh
GIVEN NAMESBertalan
FAMILY NAMENémeth
SIGNATURENEMETH B
AFFILIATIONSSyreon Research Institute (Hungary)
ORCID0000-0002-6513-5147
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2023
H-INDEX0

  • Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe

    Open AccessThi Hao Pham, Ekkehard Beck et al.ARTICLEFrontiers in Public Health2023

    Objectives Delaying of policies for immunization of aging adults, low vaccine uptake, and the lack of supportive evidence at the national level could diminish the value in health and economics of such programs. This study aims to develop a “country score tool” to assess readiness and to facilitate evidence generation for aging adult immunization programs in Europe, and examine the comprehensiveness, relevance, acceptability, and feasibility of th…

  • Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment

    Open AccessAntal Zemplényi, Konstantin Tachkov et al.ARTICLEFrontiers in Public Health2023

    Background: Artificial intelligence (AI) has attracted much attention because of its enormous potential in healthcare, but uptake has been slow. There are substantial barriers that challenge health technology assessment (HTA) professionals to use AI-generated evidence for decision-making from large real-world databases (e.g., based on claims data). As part of the European Commission-funded HTx H2020 (Next Generation Health Technology Assessment) …

  • Recommendations for patient involvement in health technology assessment in Central and Eastern European countries

    Open AccessIvett Jakab, Maria Dimitrova et al.ARTICLEFrontiers in Public Health2023

    Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the …

  • Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries

    Open AccessMaria Dimitrova, Ivett Jakab et al.ARTICLEFrontiers in Public Health2022

    Patients' perspectives are important to identify preferences, estimate values and appreciate unmet medical needs in the process of research and development and subsequent assessment of new health technologies. Patient and public involvement in health technology assessment (HTA) is essential in understanding and assessing wider implications of coverage and reimbursement decisions for patients, their relatives, caregivers, and the general populatio…

  • Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries

    Open AccessKonstantin Tachkov, Antal Zemplényi et al.ARTICLEFrontiers in Public Health2022

    The aim of this paper is to identify the barriers that are specifically relevant to the use of Artificial Intelligence (AI)-based evidence in Central and Eastern European (CEE) Health Technology Assessment (HTA) systems. The study relied on two main parallel sources to identify barriers to use AI methodologies in HTA in CEE, including a scoping literature review and iterative focus group meetings with HTx team members. Most of the other selected …